We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Has The Pharmaceuticals Native Starch Market Size Shifted, And What Is the Outlook Through 2034?

The growth of the pharmaceutical native starch market has been robust over recent years. The market which stood at $5.65 billion in 2024 is projected to escalate to $6.17 billion by 2025, delivering a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this significant growth in the past include a heightened demand for natural excipients, a surge in pharmaceutical manufacturing, an increased inclination towards biocompatible ingredients, an expansion of generic drug manufacturing, and increased regulatory backing for natural constituents.

Expectations for the pharmaceutical native starch market size predict robust expansion in the years to come, rising to the value of $8.69 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period can be attributed to factors such as increased investments in pharmaceutical innovation, a growing emphasis on sustainable sourcing, extended applications in innovative drug formulations, a rise in demand for pharmaceutical products with clean labels, and increased healthcare expenditures in developing markets. Future trends projected during this period are technological advancements in starch processing, innovations in systems for drug delivery, progress in bio-based pharmaceutical ingredients, as well as research and development in plant-based excipients, and development of solubility and stability solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Pharmaceuticals Native Starch Market?

The escalating occurrence of chronic illnesses is anticipated to spur the expansion of the pharmaceuticals native starch market. Chronic illnesses are enduring health issues that usually progress at a slow pace and last for over a year. The surge in chronic illnesses is mainly due to the increasing elderly population who are more prone to persistent ailments such as diabetes, cardiovascular diseases, arthritis, and cancer; these health issues commonly increase with age. The pharmaceuticals native starch aids in chronic disease management by boosting drug formulation stability, improving bioavailability, providing controlled drug release, assisting patient adherence, and ultimately reinforcing the effectiveness and long-term control of chronic health conditions. For instance, in June 2024, the Australian Institute of Health and Welfare, a government organization in Australia, reported a rise in the mortality rate due to chronic conditions, surging from 459 per 100,000 individuals in 2021 to 490 per 100,000 individuals in 2022. Hence, the escalating occurrence of chronic diseases is fueling the growth of the pharmaceuticals native starch market.

What Segment Types Define the Pharmaceuticals Native Starch Market Structure?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Pharmaceuticals Native Starch Market?

Leading businesses in the native starch market for pharmaceuticals are prioritizing the creation of innovative plant-based textured products to optimize medication formulation and increase patient adherence. Plant-based texture, derived from plant ingredients like thickness and gel strength, aids pharmaceutical companies in utilizing native starch to improve tablet binding, disintegration, and mouthfeel for more natural drug formulations. For example, Ingredion Incorporated, a food company based in the US, introduced Novation Indulge 2940 starch in February 2024 — a clean-label texturizer targeted at improving texture and stability in dairy and non-dairy products. This novel native starch for pharmaceutical use offers functional characteristics that boost medication formulation effectiveness, bioavailability, and timed release while promoting the creation of clean-label, eco-friendly products. NOVATION Indulge 2940 starch is a flexible ingredient that enhances texture, stability, and consumer approval in dairy and non-dairy products, utilizing clean-label, natural constituents.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Is the Definition of the Pharmaceuticals Native Starch Market?

Pharmaceutical native starch is unaltered starch derived from natural sources such as corn, potato, wheat, or tapioca and utilized as an excipient in pharmaceutical formulations. It functions as a binder, disintegrant, or filler in tablets and capsules, helping to control medication release, increase stability, and maintain appropriate tablet formation without requiring chemical or physical change.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model